ERBB2 and gastric cancer: For example, accumulating evidence showed that overexpression of Human epidermal growth factor receptor-2 (HER2) could promote proliferation, migration and infiltration of gastric cancer cells, which has also been used in the targeted therapy of gastric cancer (27–29).